Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Massel

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bailliere'S Clinical Haematology|July 1, 1990
Fibrinolytic therapy in coronary artery diseaseJ B Gill, D Massel, J Cairns
Clinical Cardiology|September 1, 1990
Management of the patient following coronary thrombolysisD Massel, J B Gill, J A Cairns
The Canadian Journal of Cardiology|June 3, 1999
Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteriesS M Renner, D Massel, B C Moon
The Canadian Journal of Cardiology|September 1, 1991
Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarctionD Massel, J B Gill, J A Cairns
American Heart Journal|August 5, 2000
Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibilityD Massel, J A Dawdy, L J Melendez
Echocardiography (Mount Kisco, N.Y.)|February 24, 2005
Ejection fraction velocity ratio as an indicator of aortic stenosis severityA M Al-Ghamdi, L J Melendez, D Massel
Chest|January 24, 1998
A systematic review of the cost-effectiveness of noncardiac transitional care unitsS P Keenan, D Massel, K J Inman, et al.
The Journal of Clinical Investigation|August 1, 1990
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitorsJ I Weitz, M Hudoba, D Massel, et al.
The Canadian Journal of Cardiology|July 1, 1993
Postcoronary thrombolysis managementD Massel, J A Cairns, P W Armstrong, et al.
The Canadian Journal of Cardiology|June 1, 1994
Canadian Consensus Conference on Coronary Thrombolysis--1994 updateJ Cairns, P Armstrong, I Belenkie, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bailliere'S Clinical Haematology|July 1, 1990
Fibrinolytic therapy in coronary artery diseaseJ B Gill, D Massel, J Cairns
Clinical Cardiology|September 1, 1990
Management of the patient following coronary thrombolysisD Massel, J B Gill, J A Cairns
The Canadian Journal of Cardiology|June 3, 1999
Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteriesS M Renner, D Massel, B C Moon
The Canadian Journal of Cardiology|September 1, 1991
Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarctionD Massel, J B Gill, J A Cairns
American Heart Journal|August 5, 2000
Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibilityD Massel, J A Dawdy, L J Melendez
Echocardiography (Mount Kisco, N.Y.)|February 24, 2005
Ejection fraction velocity ratio as an indicator of aortic stenosis severityA M Al-Ghamdi, L J Melendez, D Massel
Chest|January 24, 1998
A systematic review of the cost-effectiveness of noncardiac transitional care unitsS P Keenan, D Massel, K J Inman, et al.
The Journal of Clinical Investigation|August 1, 1990
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitorsJ I Weitz, M Hudoba, D Massel, et al.
The Canadian Journal of Cardiology|July 1, 1993
Postcoronary thrombolysis managementD Massel, J A Cairns, P W Armstrong, et al.
The Canadian Journal of Cardiology|June 1, 1994
Canadian Consensus Conference on Coronary Thrombolysis--1994 updateJ Cairns, P Armstrong, I Belenkie, et al.
Pageof 4